Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, LO Wahlund, ... Journal of internal medicine 256 (3), 240-246, 2004 | 5762 | 2004 |
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ... The Lancet Neurology 6 (8), 734-746, 2007 | 5591 | 2007 |
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3631 | 2014 |
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ... Alzheimer's & dementia 10 (6), 844-852, 2014 | 2572 | 2014 |
Revising the definition of Alzheimer's disease: a new lexicon B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ... The Lancet Neurology 9 (11), 1118-1127, 2010 | 2457 | 2010 |
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1537 | 2015 |
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1431 | 2009 |
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium … F Portet, PJ Ousset, PJ Visser, GB Frisoni, F Nobili, P Scheltens, B Vellas, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (6), 714-718, 2006 | 865 | 2006 |
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease GB Karas, P Scheltens, SARB Rombouts, PJ Visser, RA van Schijndel, ... Neuroimage 23 (2), 708-716, 2004 | 739 | 2004 |
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA … PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ... The Lancet Neurology 8 (7), 619-627, 2009 | 724 | 2009 |
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 629 | 2015 |
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ... The Lancet Neurology 16 (8), 661-676, 2017 | 627 | 2017 |
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ... The Lancet Neurology 12 (10), 957-965, 2013 | 624 | 2013 |
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 571 | 2019 |
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment PJ Visser, FRJ Verhey, PAM Hofman, P Scheltens, J Jolles Journal of Neurology, Neurosurgery & Psychiatry 72 (4), 491-497, 2002 | 482 | 2002 |
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment ESC Korf, LO Wahlund, PJ Visser, P Scheltens Neurology 63 (1), 94-100, 2004 | 465 | 2004 |
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 15 (7), 888-898, 2019 | 434 | 2019 |
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment PJ Visser, P Scheltens, FRJ Verhey, B Schmand, LJ Launer, J Jolles, ... Journal of neurology 246, 477-485, 1999 | 414 | 1999 |
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ... Brain 138 (5), 1327-1338, 2015 | 383 | 2015 |
Optimizing patient care and research: the Amsterdam Dementia Cohort WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ... Journal of Alzheimer's disease 41 (1), 313-327, 2014 | 380 | 2014 |